A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode. CN138-146 LT is the 26-week Open Label Extension Phase of the Above Titled Protocol, CN138-146 ST.
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008054/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate several doses of aripiprazole in patients with
bipolar depression.
提供机构：
Vivli
创建时间：
2022-06-27
